Alpha Synuclein, cellular dysfunction and Parkinson disease
Alpha Synuclein, cellular dysfunction and Parkinson disease
批准号:
8156800
负责人:
Mark Cookson
金额:
$5.89万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
α-突触核蛋白是第一个被鉴定为帕金森病的基因,并且与细胞和动物模型中的许多有害影响有关。 该蛋白本身在神经元中以高水平表达,在神经元中其与包括突触前囊泡的膜结构相关。 一个困难的问题是,为什么a-突触核蛋白至少在某些情况下会导致神经元死亡。 一种可能性是神经递质代谢的方面是重要的,并且我们先前已经表明某些神经元组比其他神经元组更容易受到α-突触核蛋白毒性的影响。 多巴胺能细胞特别脆弱,我们最近报道,增加α-突触核蛋白的表达使人神经母细胞瘤细胞更容易受到多巴胺相关毒性的影响。 实验室正在进行的工作旨在了解a-突触核蛋白的正常和毒性功能。
英文摘要
Alpha-synuclein was the first gene identified for Parkinsons disease and has been associated with a number of detrimental effects in cells and in animal models. The protein itself is expressed at high levels in neurons where it is associated with membranous structures including presynaptic vesicles. One difficult question is why a-synuclein would, at least in some circumstances, lead to the death of neurons. One possibility is that aspects of neurotransmitter metabolism are important and we have previously shown that some groups of neurons are more susceptible than others to a-synuclein toxicity. Dopaminergic cells are especially vulnerable and we have recently reported that increasing expression of a-synuclein makes human neuroblastoma cells more susceptible to dopamine associated toxicity. Ongoing work in the lab is aimed at understanding the normal and toxic functions of a-synuclein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene expression in the human brain
-
批准号:8736661
-
项目类别:
-
资助金额:$25.35万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
-
批准号:8552524
-
项目类别:
-
资助金额:$64.96万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Alpha Synuclein, cellular dysfunction and Parkinson disease
-
批准号:8736655
-
项目类别:
-
资助金额:$42.24万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Alpha Synuclein, cellular dysfunction and Parkinson disease
-
批准号:8931626
-
项目类别:
-
资助金额:$58.45万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
DJ-1 and hexokinases
-
批准号:9552524
-
项目类别:
-
资助金额:$21.14万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
DJ-1 function and oxidative stress
-
批准号:8552528
-
项目类别:
-
资助金额:$34.98万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
GTPase function of Leucine rich repeat kinase 2
-
批准号:8335973
-
项目类别:
-
资助金额:$33.52万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
-
批准号:8335982
-
项目类别:
-
资助金额:$54.47万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Alpha Synuclein, cellular dysfunction and Parkinson disease
-
批准号:8552517
-
项目类别:
-
资助金额:$17.49万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Genetic Variants Associated with AD/ADRD
-
批准号:10012630
-
项目类别:
-
资助金额:$12.98万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Alpha Synuclein, cellular dysfunction and Parkinson disease
-
批准号:10005771
-
项目类别:
-
资助金额:$155.9万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
DJ-1 and hexokinases
-
批准号:10005777
-
项目类别:
-
资助金额:$56.3万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
GTPase function of Leucine rich repeat kinase 2
-
批准号:10005770
-
项目类别:
-
资助金额:$97.01万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
DJ-1 function and oxidative stress (Inter-lab project)
-
批准号:10250926
-
项目类别:
-
资助金额:$42.8万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Genetic Variants Associated with AD/ADRD
-
批准号:10250905
-
项目类别:
-
资助金额:$33.32万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Developing a single cell map of the aging human brain relevant to Alzheimer's disease
-
批准号:10688829
-
项目类别:
-
资助金额:$6.7万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Alpha Synuclein, cellular dysfunction and Parkinson disease
-
批准号:10688880
-
项目类别:
-
资助金额:$116.44万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
Recessive parkinsonism and mitochondrial function
-
批准号:9351988
-
项目类别:
-
资助金额:$18.25万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
GTPase function of Leucine rich repeat kinase 2
-
批准号:10913167
-
项目类别:
-
资助金额:$24.87万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
DJ-1 function and oxidative stress
-
批准号:8148363
-
项目类别:
-
资助金额:$27.5万
-
财政年份:--
-
负责人:Mark Cookson
-
依托单位:
海外基金